Correction, focus and drive is critical for the Company. Holders are just here, for what ever ride, good or bad there is.
In the end this ann while nice is not a driver as we already have trials that are or are not underway, that are or are not completed and that may or may not progress. This does build on a potential body of work but we are a long way off.
I for one just hope on Covid or MnD to provide a shorter time frame shot in the arm to the SP. As I think the cancer market veterinarian or otherwise is still a long way off being a driver for us.
If there was another Elanco really sitting in the wings with baited breath waiting to swoop we would have that news by now. Yes I know that they are talking with VET majors etc but again that just means hey guys we may have something here. I speak to many pharma's when I go to the chemist too....(probably too cheeky a dig)
In any case as usual with PAA the SP talks and this one said minor interest on miniscule amounts but not a driver.
- Forums
- ASX - By Stock
- PAA
- Ann: PharmAust Expands Lymphoma Canine Trial to the USA
Ann: PharmAust Expands Lymphoma Canine Trial to the USA, page-24
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.010(4.65%) |
Mkt cap ! $109.4M |
Open | High | Low | Value | Volume |
21.5¢ | 22.5¢ | 21.5¢ | $347.6K | 1.569M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 38000 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 297083 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 38000 | 0.225 |
8 | 258779 | 0.220 |
11 | 874363 | 0.215 |
5 | 120849 | 0.210 |
3 | 148485 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 297083 | 9 |
0.235 | 170709 | 3 |
0.240 | 214527 | 3 |
0.250 | 333860 | 7 |
0.260 | 410162 | 3 |
Last trade - 11.56am 14/10/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |